Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 396

1.

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.

Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F; Microbs Study Group..

Int J Antimicrob Agents. 2015 Dec;46(6):622-30. doi: 10.1016/j.ijantimicag.2015.07.022.

PMID:
26453147
2.

Postoperative abdominal adhesions and bowel obstruction. A survey among Dutch general practitioners.

Leclercq RM, Van Barneveld KW, Schreinemacher MH, Assies R, Twellaar M, Bouvy ND, Muris JW.

Eur J Gen Pract. 2015;21(3):176-82. doi: 10.3109/13814788.2015.1055466.

PMID:
26161685
3.

In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract infections in France.

Auzou M, Caillon J, Poyart C, Weber P, Ploy MC, Leclercq R, Cattoir V.

Med Mal Infect. 2015 Jul;45(7):293-6. doi: 10.1016/j.medmal.2015.04.009.

PMID:
26055628
4.

Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity.

Burdet C, Clermont O, Bonacorsi S, Laouénan C, Bingen E, Aujard Y, Mentré F, Lefort A, Denamur E; COLIBAFI Group..

Pediatr Infect Dis J. 2014 Aug;33(8):872-9. doi: 10.1097/INF.0000000000000309.

PMID:
25222308
5.

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses.

Surgers L, Bleibtreu A, Burdet C, Clermont O, Laouénan C, Lefort A, Mentré F, Carbonne B, Bingen E, Meynard JL, Denamur E; COLIBAFI Group..

Clin Microbiol Infect. 2014 Dec;20(12):O1035-41. doi: 10.1111/1469-0691.12742.

6.

Unique blood culture for diagnosis of bloodstream infections in emergency departments: a prospective multicentre study.

Dargère S, Parienti JJ, Roupie E, Gancel PE, Wiel E, Smaiti N, Loiez C, Joly LM, Lemée L, Pestel-Caron M, du Cheyron D, Verdon R, Leclercq R, Cattoir V; UBC study group..

Clin Microbiol Infect. 2014 Nov;20(11):O920-7. doi: 10.1111/1469-0691.12656.

7.

Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome.

Roubaud Baudron C, Panhard X, Clermont O, Mentré F, Fantin B, Denamur E, Lefort A; COLIBAFI Group..

Epidemiol Infect. 2014 Dec;142(12):2672-83. doi: 10.1017/S0950268814000211.

PMID:
24559489
8.

Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.

Skurnik D, Roux D, Cattoir V, Danilchanka O, Lu X, Yoder-Himes DR, Han K, Guillard T, Jiang D, Gaultier C, Guerin F, Aschard H, Leclercq R, Mekalanos JJ, Lory S, Pier GB.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20747-52. doi: 10.1073/pnas.1221552110.

9.

Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.

Marcadé G, Micol JB, Jacquier H, Raskine L, Donay JL, Nicolas-Viaud S, Rouveau M, Ribaud P, Dombret H, Leclercq R, Cambau E.

J Antimicrob Chemother. 2014 Feb;69(2):500-5. doi: 10.1093/jac/dkt376.

10.

Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients.

Clermont O, Glodt J, Burdet C, Pognard D, Lefort A, Branger C, Denamur E; COLIBAFI Group Members..

Int J Med Microbiol. 2013 Dec;303(8):529-32. doi: 10.1016/j.ijmm.2013.07.002.

PMID:
23927963
11.

Genetic basis for in vitro and in vivo resistance to lincosamides, streptogramins A, and pleuromutilins (LSAP phenotype) in Enterococcus faecium.

Isnard C, Malbruny B, Leclercq R, Cattoir V.

Antimicrob Agents Chemother. 2013 Sep;57(9):4463-9. doi: 10.1128/AAC.01030-13.

12.

The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Schlusselhuber M, Torelli R, Martini C, Leippe M, Cattoir V, Leclercq R, Laugier C, Grötzinger J, Sanguinetti M, Cauchard J.

Antimicrob Agents Chemother. 2013 Oct;57(10):4615-21. doi: 10.1128/AAC.02044-12.

13.

Lincosamide resistance mediated by lnu(C) (L phenotype) in a Streptococcus anginosus clinical isolate.

Gravey F, Galopin S, Grall N, Auzou M, Andremont A, Leclercq R, Cattoir V.

J Antimicrob Chemother. 2013 Nov;68(11):2464-7. doi: 10.1093/jac/dkt255.

14.

Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.

Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C; PREVERT Investigators..

PLoS One. 2013 Jun 14;8(6):e65776. doi: 10.1371/journal.pone.0065776.

15.

Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.

Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A; GERPA Study Group..

J Antimicrob Chemother. 2013 Aug;68(8):1763-71. doi: 10.1093/jac/dkt115.

16.

Aspergillus vertebral osteomyelitis in immunocompetent subjects: case report and review of the literature.

Nicolle A, de la Blanchardière A, Bonhomme J, Hamon M, Leclercq R, Hitier M.

Infection. 2013 Aug;41(4):833-40. doi: 10.1007/s15010-013-0463-6. Review.

PMID:
23625788
17.

Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: emergence of a mupirocin-resistant MRSA clone harbouring mupA.

Desroches M, Potier J, Laurent F, Bourrel AS, Doucet-Populaire F, Decousser JW; Microbs Study Group..

J Antimicrob Chemother. 2013 Aug;68(8):1714-7. doi: 10.1093/jac/dkt085.

18.

Changes in enterococcal populations and related antibiotic resistance along a medical center-wastewater treatment plant-river continuum.

Leclercq R, Oberlé K, Galopin S, Cattoir V, Budzinski H, Petit F.

Appl Environ Microbiol. 2013 Apr;79(7):2428-34. doi: 10.1128/AEM.03586-12.

19.

Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?

Cattoir V, Leclercq R.

J Antimicrob Chemother. 2013 Apr;68(4):731-42. doi: 10.1093/jac/dks469. Review.

20.

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.

Morrissey I, Seifert H, Canton R, Nordmann P, Stefani S, Macgowan A, Janes R, Knight D; Oritavancin Study Group..

J Antimicrob Chemother. 2013 Jan;68(1):164-7. doi: 10.1093/jac/dks344.

Items per page

Supplemental Content

Loading ...
Support Center